T0	Participants 47 93	patients insufficiently controlled on timolol.
T1	Participants 233 342	patients with open angle glaucoma or ocular hypertension where IOP is not adequately controlled with timolol.
T2	Participants 416 570	53 patients with primary open angle glaucoma, capsular glaucoma, or ocular hypertension with an IOP of at least 21 mmHg on current therapy were recruited.